4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-318105
CEO acquired 4,568 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Weis Holger · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-23 | Grant or award : show line 1 in the form | +4,568 | $1.92 | $8,771 | 21,120 | D |
Loading xslF345X06/ownership.xml…